Dr. Nazeer's areas of interest include hematopathology and urologic pathology. He has been studying large cell lymphomas with a special emphasis on cell cycle pathways and potential targets for therapeutic intervention. Dr. Nazeer is a professor at Albany Medical College.

Dr. Nazeer is an active member of the upstate hematology group promoting research and education. He has authored 67 articles in peer reviewed journals and multiple textbook chapters. Dr. Nazeer has been involved in the development of international society of urologic pathology (ISUP) grading and Vancouver classification, as well as diagnostic and prognostic markers of renal tumors.

Selected recent publications:

Wiernik PH, Li H, Weller E, Hochster HS, Horning SJ, Nazeer T, Gordon LI, Habermann TM, Minniti CJ, Shapiro GR, Cassileth PA.Activity of Topotecan 21-Day Infusion in Patients with Previously Treated Large Cell Lymphoma: Long-term follow-up of an Eastern Cooperative Oncology Group Study (E5493). Leukemia & Lymph, 2012 Jun;53(6): 1173-42.

Wadad MS, Nazeer T, Homan S. Entopathy-associated anaplastic large T-cell lymphoma ALK-posiitve(EA-ALCL:-ALK+): variant of T-cell lymphoma with possible two hit pathogenesis. Journal of Hematopathology 2013; s12308-013

Renal tumors: diagnostic and prognostic biomarkers. Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H; ISUP Renal Tumor Panel. Am J Surg Pathol. 2013 Oct;37(10):1518-31.

Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H,Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR; members of the ISUP Renal Tumor Panel. Am J Surg Pathol. 2013 Oct;37(10):1505-17.

The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, Montironi R, Srigley JR; Members of the ISUP Renal Tumor Panel. Am J Surg Pathol. 2013 Oct;37(10):1490-504.

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel. Am J Surg Pathol. 2013 Oct;37(10):1469-89.

Ross JS, Wang K, Khaira D, Ali SM, Fisher HA, Mian B, Nazeer T, Elvin JA, Palma N, Yelensky R, Lipson D, Miller VA, Stephens PJ, Subbiah V, Pal SK. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations. Cancer. 2016 Mar 1;122(5):702-11.